Skip to main content
Recent Quotes
My Watchlist
Indicators
Markets
Stocks
ETFs
Tools
Overview
News
Currencies
International
Treasuries

Respirerx Pharmaceuticals Inc (OP:RSPI)

0.0007 +0.0001 (+16.67%)
Streaming Delayed Price Updated: 10:09 AM EDT, May 9, 2025 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

Price and Volume

Detailed Quote
Volume 1,100,000
Open 0.0007
Bid (Size) N/A (0)
Ask (Size) N/A (0)
Prev. Close 0.0006
Today's Range 0.0007 - 0.0007
52wk Range 0.0002 - 0.0069
Shares Outstanding N/A
Dividend Yield N/A
Chart for (: )
Intraday 1 Week 1 Month 3 Month 1 Year 3 Year 5 Year

Top News

More News
Stocks Under 1¢: June 2024 Gains, July 2024 Watchlist SMCE, SPZI, RSPI, HALB, BIEI, RJDG
Via AB Newswire
RespireRx Transferes Its Pharmaceutical Cannabinoid Program To ResolutionRx
RespireRx Pharmaceuticals Inc. (OTCPK:RSPI), focused on the discovery and development of treatments to combat diseases caused by disruption of neuronal signaling, and ResolutionRx Ltd, an unlisted... 
Via Benzinga

Performance

YTD
N/A
N/A
1 Month
-69.6%
-69.6%
3 Month
-74.1%
-74.1%
6 Month
N/A
N/A
1 Year
-30.0%
-30.0%

More News

Read More
RespireRx Pharmaceuticals Inc. Enters a Collaboration With National Institute for Neurological Disorders and Stroke to Advance its Lead GABAkine Toward Clinical Development
From RespireRX Pharmaceuticals Inc.
Via GlobeNewswire
RespireRx Signs LOI With Australian CRO For Dronabinol Development For Obstructive Sleep Apnea
Via Benzinga
RespireRx Pharmaceuticals Inc. Announces Entry into Letter of Intent with Australian Headquartered CRO for Dronabinol Development for Obstructive Sleep Apnea
From RespireRX Pharmaceuticals Inc.
Via GlobeNewswire
RespireRx Pharmaceuticals Inc. Announces that Jeff Margolis, the Company’s CFO is presenting at the Investor Summit Q4
From RespireRX Pharmaceuticals Inc.
Via GlobeNewswire
RespireRx Pharmaceuticals Inc. Announces that Dr. Arnold Lippa Is an Invited Speaker at the 5th Meridian Drug Discovery Summit
From RespireRX Pharmaceuticals Inc.
Via GlobeNewswire
RespireRx Pharmaceuticals Files Patent: Claims To Improve Solubility & Bioavailability Of Cannabinoids
Via Benzinga
Epigenetics, Psychedelics and Stem Cell Therapy are Topics of the Life Sciences Virtual Investor Conference Launching This Thursday
Via Benzinga

Frequently Asked Questions

Is Respirerx Pharmaceuticals Inc publicly traded?
Yes, Respirerx Pharmaceuticals Inc is publicly traded.
What exchange does Respirerx Pharmaceuticals Inc trade on?
Respirerx Pharmaceuticals Inc trades on the OTC Traded
What is the ticker symbol for Respirerx Pharmaceuticals Inc?
The ticker symbol for Respirerx Pharmaceuticals Inc is RSPI on the OTC Traded
What is the current price of Respirerx Pharmaceuticals Inc?
The current price of Respirerx Pharmaceuticals Inc is 0.0007
When was Respirerx Pharmaceuticals Inc last traded?
The last trade of Respirerx Pharmaceuticals Inc was at 05/09/25 10:09 AM ET
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms Of Service.